SELLAS Life Sciences Group Inc (SLS)
0.9504
-0.10
(-9.49%)
USD |
NASDAQ |
Jan 08, 16:00
0.9699
+0.02
(+2.05%)
After-Hours: 20:00
SELLAS Life Sciences Group SG&A Expense (Quarterly): 2.967M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Microbot Medical Inc | 1.24M |
| Alaunos Therapeutics Inc | 1.007M |
| Galectin Therapeutics Inc | 1.471M |
| Oragenics Inc | 1.558M |
| Anavex Life Sciences Corp | 2.781M |